Trademark Search in Canada

TIVDAKT

View On IC.GC.CA

REGISTERED

Last Applicant/ Owned by

Seagen Inc.

21823 30th Drive S.E.Bothell WA 98021

Serial Number

2162380 filed on 25^th Oct 2021

Registration Number

TMA1237065 registered on 7^th Jun 2024

Registration expiry Date

25^th Oct 2031

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

M5X1G5

TIVDAKT

Trademark usage description

pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of nervous system diseases, for the Read More

Classification Information

Class [005]
Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of nervous system diseases, for the regulation of the immune system and for treatment of auto-immune diseases, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of cancer, and inflammatory disorders, for use in dermatology namely dermatitis, skin pigmentation diseases, acne, eczema, psoriasis, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology namely dermatitis, skin pigmentation diseases, acne, eczema, psoriasis, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology

Classification kind code

Class [042]
Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation

Classification kind code

Mark Details

Serial Number

2162380

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 16^th Mar 2023	Agent Changed
Submitted for opposition 22 on 10^th Mar 2023	Search Recorded
Submitted for opposition 20 on 10^th Mar 2023	Examiner's First Report
Submitted for opposition 223 on 10^th Mar 2023	Total Provisional Refusal
Submitted for opposition 256 on 28^th Nov 2022	Notification of Possible Opposition Sent
Submitted for opposition 257 on 27^th Jan 2022	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 26^th Jan 2022	Formalized
Submitted for opposition 1 on 26^th Jan 2022	Created
Submitted for opposition 228 on 25^th Oct 2021	International Registration
Submitted for opposition 30 on 25^th Oct 2021	Filed